Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)
- CUSIP: 92532F100
- Is VRTX overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on VRTX
Who owns Vertex Pharmaceuticals Incorporated?
Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.
|Fund Name||Number of Shares||Share Valuation||As Of|
|OTR - Nominee Name for The State Teachers Retirement Board of Ohio||33.87M||$33.53M||March 31, 2015|
|Capital World Investors^||23.45M||$2.77B||March 31, 2015|
|FMR||16.51M||$2.04B||June 30, 2015|
|Wellington Management Company||13.88M||$1.71B||June 30, 2015|
|Vanguard||13.85M||$1.71B||June 30, 2015|
|T. Rowe Price Associates||13.52M||$1.59B||March 31, 2015|
|JPMORGAN CHASE & CO||10.58M||$1.31B||June 30, 2015|
|Ameriprise Financial||9.87M||$1.22B||June 30, 2015|
|STATE STREET CORPORATION||9.65M||$1.19B||June 30, 2015|
|ClearBridge Advisors||7.93M||$935.04M||March 31, 2015|
|GOLDMAN SACHS||6.63M||$502.84M||Sept. 30, 2013|
|Jennison Associates||6.55M||$772.53M||March 31, 2015|
|BlackRock Institutional Trust Company, N.A.||6.38M||$788.34M||June 30, 2015|
|BlackRock Fund Advisors||6.30M||$743.75M||March 31, 2015|
Who sold Vertex Pharmaceuticals Incorporated?
|Fund Name||Date Sold||Number of Shares Sold||Share Valuation|
|D. E. Shaw & Co||Dec. 31, 2010||7.48M||$262.12M|